Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL), Human Aminoacyl multi- tRNA synthetase complex (MSC)

Bahaa's PhD at The University of Queensland's Australian Institute of Bioengineering and Nanotechnology focuses on white matter disease, specifically an ultra-rare inherited neuro degenerative condition known as Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL).

In the Wolvetang Group, Bahaa is generating brain organoids that are used to test the underlying mechanisms that may lead to the signs and symptoms in HBSL patients.

As an entrepreneurial scholar in the UQ Entrepreneurial PhD Top-Up Scholarship program, he is also well aware of the importance of working with industry in mind – both because of commercial realities of research, and the potential to scale up the number of people who can be helped.

Featured projects Duration
Understanding and treating childhood white matter disease
20212024